Liver stiffness measurements by 2-dimensional shear wave elastography compared to histological and ultrasound parameters in primary biliary cholangitis

Liver stiffness measurements (LSMs) by 2-dimensional-shear-wave elastography (LSM 2D-SWE ) are now widely used in hepatology. However, relevant information for primary biliary cholangitis (PBC) is scant. We compare LSM 2D-SWE with liver biopsy (LB) in a cohort of PBC patients in Greece. Data of 68 L...

Full description

Saved in:
Bibliographic Details
Published in:Scandinavian journal of gastroenterology Vol. 56; no. 10; pp. 1187 - 1193
Main Authors: Manesis, Emanuel K., Schina, Maria, Vafiadis, Irene, Gatos, Ilias, Theotokas, John, Zoumpoulis, Pavlos, Drazinos, Peter, Ketikoglou, John, Delladetsima, Ioanna K., Tiniakos, Dina G.
Format: Journal Article
Language:English
Published: Taylor & Francis 03-10-2021
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Liver stiffness measurements (LSMs) by 2-dimensional-shear-wave elastography (LSM 2D-SWE ) are now widely used in hepatology. However, relevant information for primary biliary cholangitis (PBC) is scant. We compare LSM 2D-SWE with liver biopsy (LB) in a cohort of PBC patients in Greece. Data of 68 LBs from 53 PBC patients were retrospectively analyzed and fibrosis stage was compared to LSM 2D-SWE . Forty-six patients (86.8%) were females and at the time of LBx median (IQR) age was 62.6 (53.2-72.1). Demographic, UDCA treatment, histological and B-mode ultrasound data were tested for their influence on LSM 2D-SWE estimates. Liver fibrosis stages F0-F4 were found in 4, 19, 19, 16 and 10 cases, respectively. Across stages F0-F4, the LSM 2D-SWE was 5.6 (5.1-6.1), 7.0 (5.8-7.7), 9.1 (7.3-11.5), 10.8 (9.9-12.2) and 14.5 (11.9-25.7) kPa, respectively, with highly significant difference (p<.001). The LSM 2D-SWE differed also significantly between F0 vs. F1 (p=.027), F1 vs. F2 (p=.005) and F3 vs. F4 (p=.017). The discriminatory ability of LSM 2D-SWE for mild, significant, severe fibrosis and cirrhosis was highly significant in all comparisons (p<.001), with AUC 2D-SWE 95.3%, 87.4%, 85.3% and 95.3% and accuracy 89.7%, 85.3%, 80.9% and 86.8%, respectively. Among 21 parameters tested, significant predictors of LSM 2D-SWE by multiple linear regression were fibrosis stage, portal inflammation and parenchymal heterogeneity. The portal inflammation grade accounted for 32.2% of LSM variation with adjusted R 2 0.428. In patients with PBC, LSM measurements by 2D-SWE can reliably discriminate between mild, significant, severe fibrosis and cirrhosis. Measurements are significantly affected by portal inflammation grade.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0036-5521
1502-7708
DOI:10.1080/00365521.2021.1928277